CRL
Charles River Laboratories
NYSE: CRL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$163.84
-1.77% today
Updated 2026-04-29
Market cap
$8.23B
P/E ratio
—
P/S ratio
2.05x
EPS (TTM)
$-2.90
Dividend yield
—
52W range
$114 – $229
Volume
1.0M
Charles River Laboratories (CRL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.06B | $1.23B | $1.34B | $1.20B | $1.13B | $1.14B | $1.13B | $1.17B | $1.30B | $1.36B | $1.68B | $1.86B | $2.27B | $2.62B | $2.92B | $3.54B | $3.98B | $4.13B | $4.05B | $4.02B |
| Revenue growth (YoY) | — | +16.3% | +9.2% | -10.5% | -5.7% | +0.8% | -1.1% | +3.2% | +11.3% | +5.1% | +23.3% | +10.5% | +22.0% | +15.7% | +11.5% | +21.1% | +12.3% | +3.9% | -1.9% | -0.9% |
| Cost of revenue | $651.78M | $752.43M | $832.78M | $748.65M | $748.66M | $740.40M | $737.45M | $770.63M | $825.00M | $832.21M | $1.04B | $1.16B | $1.43B | $1.66B | $1.85B | $2.21B | $2.51B | $2.63B | $2.72B | $2.79B |
| Gross profit | $406.61M | $478.19M | $510.71M | $422.99M | $384.76M | $402.24M | $392.08M | $394.90M | $472.66M | $531.09M | $643.96M | $700.92M | $840.07M | $958.31M | $1.07B | $1.33B | $1.46B | $1.50B | $1.33B | $1.23B |
| Gross margin | 38.4% | 38.9% | 38.0% | 35.2% | 33.9% | 35.2% | 34.7% | 33.9% | 36.4% | 39.0% | 38.3% | 37.7% | 37.1% | 36.6% | 36.7% | 37.7% | 36.8% | 36.4% | 32.9% | 30.5% |
| R&D | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| SG&A | $180.80M | $217.50M | $230.20M | $234.00M | $226.80M | $198.65M | $206.90M | $223.90M | $263.50M | $282.58M | $367.55M | $364.76M | $419.72M | $486.20M | $528.93M | $619.92M | $665.10M | $750.35M | $751.00M | $723.42M |
| Operating income | $188.17M | $227.19M | $-449.76M | $169.61M | $-298.51M | $174.31M | $165.76M | $151.40M | $177.67M | $206.45M | $237.55M | $288.28M | $331.38M | $351.15M | $432.73M | $589.86M | $650.98M | $617.26M | $227.35M | $507.84M |
| Operating margin | 17.8% | 18.5% | -33.5% | 14.1% | -26.3% | 15.3% | 14.7% | 13.0% | 13.7% | 15.1% | 14.1% | 15.5% | 14.6% | 13.4% | 14.8% | 16.7% | 16.4% | 14.9% | 5.6% | 12.6% |
| EBITDA | $273.30M | $321.81M | $-355.82M | $263.20M | $-205.15M | $260.48M | $244.36M | $255.93M | $285.99M | $305.38M | $377.29M | $457.89M | $507.23M | $563.06M | $768.47M | $820.16M | $986.15M | $1.03B | $581.14M | $911.15M |
| EBITDA margin | 25.8% | 26.1% | -26.5% | 21.9% | -18.1% | 22.8% | 21.6% | 22.0% | 22.0% | 22.4% | 22.4% | 24.6% | 22.4% | 21.5% | 26.3% | 23.2% | 24.8% | 25.0% | 14.3% | 22.7% |
| EBIT | $188.17M | $235.43M | $-447.00M | $173.24M | $-298.80M | $175.25M | $163.09M | $159.30M | $189.54M | $210.50M | $250.63M | $326.73M | $345.45M | $364.97M | $533.55M | $554.62M | $682.28M | $717.99M | $219.40M | $507.84M |
| Interest expense | $193.24M | $14.83M | $14.01M | $21.68M | $34.09M | $41.23M | $33.34M | $20.97M | $11.95M | $15.07M | $27.71M | $29.78M | $63.77M | $60.88M | $86.43M | $73.91M | $59.29M | $136.71M | $126.29M | $107.03M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-55.78M | $154.41M | $-521.84M | $114.44M | $-336.67M | $109.57M | $97.30M | $102.83M | $126.70M | $149.31M | $154.76M | $123.36M | $226.37M | $252.02M | $364.30M | $390.98M | $486.23M | $474.62M | $10.30M | $-144.34M |
| Net income growth (YoY) | — | +376.8% | -438.0% | +121.9% | -394.2% | +132.5% | -11.2% | +5.7% | +23.2% | +17.8% | +3.7% | -20.3% | +83.5% | +11.3% | +44.6% | +7.3% | +24.4% | -2.4% | -97.8% | -1501.7% |
| Profit margin | -5.3% | 12.5% | -38.8% | 9.5% | -29.7% | 9.6% | 8.6% | 8.8% | 9.8% | 11.0% | 9.2% | 6.6% | 10.0% | 9.6% | 12.5% | 11.0% | 12.2% | 11.5% | 0.3% | -3.6% |